TAVR and Valve-in-Valve (Michael Reardon, MD)

Faculty Interview with Dr. Michael Reardon | CardioVascular Interventions Summit 2024Подробнее

Faculty Interview with Dr. Michael Reardon | CardioVascular Interventions Summit 2024

Medtronic Tavr | Dr. Michael Reardon | Daily FlashПодробнее

Medtronic Tavr | Dr. Michael Reardon | Daily Flash

Breaking News: Medtronic TAVR Low-Risk Clinical Trial Results Released!Подробнее

Breaking News: Medtronic TAVR Low-Risk Clinical Trial Results Released!

Michael Reardon: TMVR (Medtronic Apollo Trial)Подробнее

Michael Reardon: TMVR (Medtronic Apollo Trial)

Michael J Reardon, MD - TAVR in Asymptomatic or Moderate ASПодробнее

Michael J Reardon, MD - TAVR in Asymptomatic or Moderate AS

1.26.23 Grand Rounds: TAVR and the Lifetime Management of Aortic Stenosis: TAVR and the Lifetime ...Подробнее

1.26.23 Grand Rounds: TAVR and the Lifetime Management of Aortic Stenosis: TAVR and the Lifetime ...

Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MDПодробнее

Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MD

Lifetime Management of Aortic Stenosis (Kendra J Grubb, MD, Michael Reardon, MD)Подробнее

Lifetime Management of Aortic Stenosis (Kendra J Grubb, MD, Michael Reardon, MD)

View the New Generation Navitor Vision* ValveПодробнее

View the New Generation Navitor Vision* Valve

Lifetime Management of Aortic Stenosis (Kendra J. Grubb, MD, Michael Reardon, MD)Подробнее

Lifetime Management of Aortic Stenosis (Kendra J. Grubb, MD, Michael Reardon, MD)

Redo-Aortic Valve Replaced–Annular Enlargement Y Incision & Rectangle Patch (Reardon MD, Al Abri MD)Подробнее

Redo-Aortic Valve Replaced–Annular Enlargement Y Incision & Rectangle Patch (Reardon MD, Al Abri MD)

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020Подробнее

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020

Disruptive Innovation: TAVR 20 Years Later | April 4Подробнее

Disruptive Innovation: TAVR 20 Years Later | April 4

Which Low-Risk Patients Should Receive TAVR?Подробнее

Which Low-Risk Patients Should Receive TAVR?

Aortic InnovationsПодробнее

Aortic Innovations

How Innovation Happens: Lessons from the Transcatheter Valve Trials (Michael Mack, MD) Nov. 14, 2019Подробнее

How Innovation Happens: Lessons from the Transcatheter Valve Trials (Michael Mack, MD) Nov. 14, 2019

Next generation TAVR device will enable lifetime management of AS patients - EuroPCR 2021Подробнее

Next generation TAVR device will enable lifetime management of AS patients - EuroPCR 2021

TAVR Explantation Due to Late Thrombosis Leading to Cardiogenic Shock (M Reardon, S Goel, Q Al Abri)Подробнее

TAVR Explantation Due to Late Thrombosis Leading to Cardiogenic Shock (M Reardon, S Goel, Q Al Abri)

TAVR Explantation, Root Enlargement, Aortic Valve Replacement(Wv Ballmoos MD; Reardon MD; Zubair MD)Подробнее

TAVR Explantation, Root Enlargement, Aortic Valve Replacement(Wv Ballmoos MD; Reardon MD; Zubair MD)

Transcatheter Aortic Valve Explantation – Surgical Aortic Valve Replacement (Wyler von Ballmoos, MD)Подробнее

Transcatheter Aortic Valve Explantation – Surgical Aortic Valve Replacement (Wyler von Ballmoos, MD)